Cargando…
Early Detection of Circulating Tumor DNA Postoperatively Enables Discovery of Resectable Metastatic Disease in a Patient with Colon Cancer
Currently, serum carcinoembryonic agent (CEA) along with contrast-enhanced imaging and colonoscopy are used for evaluation of recurrence of colorectal cancer. However, CEA is an unreliable and nonspecific biomarker that may fail to rise and signal relapse. Analysis of circulating tumor DNA (ctDNA) i...
Autores principales: | Weinberg, Benjamin A., Winslow, Emily R., Bayasi, Mohammed, Krainock, Michael R., Olshan, Perry M., Billings, Paul R., Aleshin, Alexey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739946/ https://www.ncbi.nlm.nih.gov/pubmed/35082635 http://dx.doi.org/10.1159/000520743 |
Ejemplares similares
-
ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in Metastatic Microsatellite Stable Colorectal Cancer with a High Tumor Mutation Burden
por: Schneider, Charles J., et al.
Publicado: (2021) -
Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2022) -
The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant
por: Cohen, Stacey A., et al.
Publicado: (2022) -
Financial burden of postoperative complications following colonic resection: A systematic review
por: Louis, Maleck, et al.
Publicado: (2021) -
Liver Resection for Metastatic Colon Carcinoma
por: Bengmark, S.
Publicado: (1989)